Matthew D. Linden
- Cardiology and Cardiovascular Medicine top 2%
- Hematology top 1%
- Surgery top 10%
- Internal Medicine top 1%
- Pharmacology top 5%
- Co-authors
- Andrew L. FrelingerAlan D. MichelsonMarsha L. FoxMarc R. BarnardMark I. FurmanDenise E. JacksonM.R. BARNARDYoufu Li
- Topics
- Platelet Disorders and Treatments (32 papers)Antiplatelet Therapy and Cardiovascular Diseases (28 papers)Venous Thromboembolism Diagnosis and Management (17 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Matthew D. Linden
81 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 121
- Cardiology and Cardiovascular Medicine 1.0k
- Hematology 763
- Surgery 409
- Internal Medicine 359
- Pharmacology 283
Countries citing papers authored by Matthew D. Linden
This map shows the geographic impact of Matthew D. Linden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew D. Linden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew D. Linden more than expected).
Fields of papers citing papers by Matthew D. Linden
This network shows the impact of papers produced by Matthew D. Linden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew D. Linden. The network helps show where Matthew D. Linden may publish in the future.
Co-authorship network of co-authors of Matthew D. Linden
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew D. Linden. A scholar is included among the top collaborators of Matthew D. Linden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew D. Linden. Matthew D. Linden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 10 | |
| 3 | 8 | |
| 4 | 15 | |
| 5 | 12 | |
| 6 | 6 | |
| 7 | 10 | |
| 8 | 20 | |
| 9 | 26 | |
| 10 | Teaching clinical trial design and management using an online virtual environment | 8 |
| 11 | 94 | |
| 12 | 5 | |
| 13 | 227 | |
| 14 | 70 | |
| 15 | 45 | |
| 16 | 39 | |
| 17 | 66 | |
| 18 | 104 | |
| 19 | 29 | |
| 20 | 8 |
About Matthew D. Linden
Matthew D. Linden is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 83 papers that have together received 2.3k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (32 papers), Antiplatelet Therapy and Cardiovascular Diseases (28 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). The work is most often cited by research in Internal Medicine (359 citations), Hematology (763 citations) and Cardiology and Cardiovascular Medicine (1.0k citations). Matthew D. Linden has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew L. Frelinger, Alan D. Michelson, Marsha L. Fox, Marc R. Barnard, Mark I. Furman, Denise E. Jackson, M.R. BARNARD, Youfu Li, Huyen Tran and Karin Przyklenk. Their work appears in journals such as Circulation, Blood and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.